全文获取类型
收费全文 | 3381篇 |
免费 | 184篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 58篇 |
妇产科学 | 15篇 |
基础医学 | 518篇 |
口腔科学 | 16篇 |
临床医学 | 156篇 |
内科学 | 458篇 |
皮肤病学 | 27篇 |
神经病学 | 667篇 |
特种医学 | 97篇 |
外科学 | 123篇 |
综合类 | 299篇 |
预防医学 | 163篇 |
眼科学 | 28篇 |
药学 | 664篇 |
中国医学 | 135篇 |
肿瘤学 | 265篇 |
出版年
2023年 | 36篇 |
2022年 | 34篇 |
2021年 | 52篇 |
2020年 | 72篇 |
2019年 | 73篇 |
2018年 | 65篇 |
2017年 | 70篇 |
2016年 | 65篇 |
2015年 | 75篇 |
2014年 | 186篇 |
2013年 | 190篇 |
2012年 | 190篇 |
2011年 | 193篇 |
2010年 | 163篇 |
2009年 | 173篇 |
2008年 | 156篇 |
2007年 | 140篇 |
2006年 | 129篇 |
2005年 | 108篇 |
2004年 | 90篇 |
2003年 | 108篇 |
2002年 | 106篇 |
2001年 | 81篇 |
2000年 | 78篇 |
1999年 | 57篇 |
1998年 | 51篇 |
1997年 | 39篇 |
1996年 | 34篇 |
1995年 | 40篇 |
1994年 | 39篇 |
1993年 | 36篇 |
1992年 | 30篇 |
1991年 | 29篇 |
1990年 | 36篇 |
1989年 | 31篇 |
1988年 | 38篇 |
1987年 | 24篇 |
1986年 | 48篇 |
1985年 | 105篇 |
1984年 | 79篇 |
1983年 | 66篇 |
1982年 | 67篇 |
1981年 | 56篇 |
1980年 | 56篇 |
1979年 | 33篇 |
1978年 | 26篇 |
1977年 | 19篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1973年 | 4篇 |
排序方式: 共有3702条查询结果,搜索用时 15 毫秒
1.
2.
Neoadjuvant Therapy with Drug Arglabin for Breast Cancer with Expression of H-Ras Oncoproteins 下载免费PDF全文
Sergazy AdekenovAinur Zhumakayeva Vladimir PerminovBakhytzhan BekmanovKayrolla Rakhimov 《Asian Pacific journal of cancer prevention》2020,21(11):3441-3447
Backgrounds: In breast cancer, blocking of Ras signaling and inhibition of H-Ras is quite promising. H-Ras may become a target for farnesyl transferase inhibitors, and in combination with other immunohistochemical factors it will contribute to the progression of a breast tumor. Purpose: The aim of this study was to evaluate the effectiveness of neoadjuvant therapy for breast cancer with the inclusion of farnesyl transferase inhibitor, arglabin interfering with the expression and concentration of H-Ras oncoproteins. Methods: Depending on the presence of H-Ras oncoproteins after Western-blot hybridization, the patients were divided a negative and positive expression of H-Ras groups. Results: Correlation analysis of methods used for determining the expression ability and concentration of H-Ras oncoproteins (immunohistochemistry and Western-blot analysis) demonstrated substantial statistical relationship Rs=0.71, p=0.03. The H-Ras oncoproteins were absent in patients receiving either “Arglabin” or standard AC regimen. However, in the AC + Arglabin group, there was a varying degrees of positive concentration of H-Ras oncoproteins (Kruskal-Wallis=6.92; p=0.03). Conclusion: These results indicate that Arglabin attenuates H-Ras oncoproteins expression which is a promising therapeutic target for breast cancer. 相似文献
3.
4.
《Drug metabolism and pharmacokinetics》2020,35(4):368-373
A recent report demonstrated that sesamin strongly and non-competitively inhibits S-warfarin 7-hydroxylation activity in human liver microsomes with a Ki value of 0.2 μM. This finding suggests that sesamin predominantly binds to CYP2C9 at another site for which it has a higher affinity than its affinity for the active site, thereby inhibiting the activity of CYP2C9 non-competitively. In this study, we found that sesamin competitively inhibited the 7-hydroxylation activity of S-warfarin in human liver microsomes with a Ki value of 15.7 μM. In addition, the recombinant CYP2C9-dependent 7-hydroxylation activity of S-warfarin was competitively inhibited by sesamin with a Ki value of 13.1 μM. These results are consistent with the fact that sesamin is a good substrate of CYP2C9, and its activity follows Michaelis-Menten kinetics. As the plasma concentration of sesamin after its administration is usually lower than 0.01 μM, the inhibition of S-warfarin metabolism by sesamin does not appear to be severe. 相似文献
5.
《药学学报(英文版)》2020,10(10):1926-1942
Acetylcholine (ACh) regulates inflammation via α7 nicotinic acetylcholine receptor (α7 nAChR). Acetylcholinesterase (AChE), an enzyme hydrolyzing ACh, is expressed in immune cells suggesting non-classical function in inflammatory responses. Here, the expression of PRiMA-linked G4 AChE was identified on the surface of macrophages. In lipopolysaccharide-induced inflammatory processes, AChE was upregulated by the binding of NF-κB onto the ACHE promotor. Conversely, the overexpression of G4 AChE inhibited ACh-suppressed cytokine release and cell migration, which was in contrast to that of applied AChE inhibitors. AChEmt, a DNA construct without enzymatic activity, was adopted to identify the protein role of AChE in immune system. Overexpression of G4 AChEmt induced cell migration and inhibited ACh-suppressed cell migration. The co-localization of α7 nAChR and AChE was found in macrophages, suggesting the potential interaction of α7 nAChR and AChE. Besides, immunoprecipitation showed a close association of α7 nAChR and AChE protein in cell membrane. Hence, the novel function of AChE in macrophage by interacting with α7 nAChR was determined. Together with hydrolysis of ACh, AChE plays a direct role in the regulation of inflammatory response. As such, AChE could serve as a novel target to treat age-related diseases by anti-inflammatory responses. 相似文献
6.
7.
8.
9.
口腔鳞癌P-gp、GST-π表达与化疗药物耐受性 总被引:1,自引:1,他引:1
目的 探讨P-糖蛋白(P-glycoprotein,P-gp)和谷胱甘肽S转移酶π(glutathione transferase-π,GST-π)表达与化疗药物耐受性的关系。方法 采用免疫组化过氧化物酶标记法检测口腔颌面部鳞癌和正常口腔粘膜组织样本中P-gp和GST-π的表达,结合MTT药敏检测结果分析。结果 P-gp和GST-π在恶性肿瘤中阳性表达率分别为57.1%和53.6%,在正常组织中未见表达;P-gp的表达与化疗药物总体耐受性有关;GST-π的表达与患者顺铂耐受性有关。结论 P-gp和GST-π的阳性表达提示患者有化疗药物耐受倾向。P-pg和GST-π检测对判断口腔颌面部恶性肿瘤化疗耐药性有指导意义。 相似文献
10.
Jean-François Brugère Guillaume Borrel Nadia Gaci William Tottey Paul W O’Toole Corinne Malpuech-Brugère 《Gut microbes》2014,5(1):5-10
Trimethylamine (TMA) is produced by gut bacteria from dietary ingredients. In individuals with a hereditary defect in flavin-containing monooxygenase 3, bacterial TMA production is believed to contribute to the symptoms of trimethylaminuria (TMAU; fish-odor syndrome). Intestinal microbiota TMA metabolism may also modulate atherosclerosis risk by affecting trimethylamine oxide (TMAO) production levels. We propose that reducing TMA formation in the gut by converting it to an inert molecule could be used to prevent or limit these human diseases, while avoiding the major drawbacks of other clinical interventions. Reducing TMA levels by microbiological interventions could also be helpful in some vaginoses. Particular members of a recently discovered group of methanogens, that are variably present in the human gut, are unusual in being apparently restricted to utilizing only methyl compounds including TMA as substrates. We confirmed experimentally that one of these strains tested, Methanomassiliicoccus luminyensis B10, is able to deplete TMA, by reducing it with H2 for methanogenesis. We therefore suggest that members of this archaeal lineage could be used as treatments for metabolic disorders. 相似文献